Copyright Reports & Markets. All rights reserved.

Global Retinal Pharmaceuticals Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Buy now

Table of Contents

    1 Market Overview

    • 1.1 Retinal Pharmaceuticals Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Macular Degeneration
      • 1.2.2 Diabetic Eye Disease
      • 1.2.3 Retinal Detachment
      • 1.2.4 Retinoblastoma
      • 1.2.5 Macular Pucker
      • 1.2.6 Macular Hole
      • 1.2.7 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital Pharmacies
      • 1.3.2 Online Pharmacies
      • 1.3.3 Independent Pharmacies
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Santen Pharmaceutical Co.,Ltd.
      • 2.1.1 Business Overview
      • 2.1.2 Retinal Pharmaceuticals Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Santen Pharmaceutical Co.,Ltd. Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Regeneron Pharmaceuticals,Inc.
      • 2.2.1 Business Overview
      • 2.2.2 Retinal Pharmaceuticals Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Regeneron Pharmaceuticals,Inc. Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Shire Plc
      • 2.3.1 Business Overview
      • 2.3.2 Retinal Pharmaceuticals Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Shire Plc Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Bayer AG
      • 2.4.1 Business Overview
      • 2.4.2 Retinal Pharmaceuticals Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Bayer AG Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Novartis International AG
      • 2.5.1 Business Overview
      • 2.5.2 Retinal Pharmaceuticals Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Novartis International AG Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Valeant Pharmaceuticals International,Inc
      • 2.6.1 Business Overview
      • 2.6.2 Retinal Pharmaceuticals Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Valeant Pharmaceuticals International,Inc Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Merck&Co.
      • 2.7.1 Business Overview
      • 2.7.2 Retinal Pharmaceuticals Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Merck&Co. Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Retinal Pharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Retinal Pharmaceuticals Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Retinal Pharmaceuticals Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Retinal Pharmaceuticals Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Retinal Pharmaceuticals Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Retinal Pharmaceuticals Market Analysis by Regions

    • 4.1 Global Retinal Pharmaceuticals Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Retinal Pharmaceuticals Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Retinal Pharmaceuticals Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 4.3 Europe Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 4.5 South America Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)

    5 North America Retinal Pharmaceuticals by Country

    • 5.1 North America Retinal Pharmaceuticals Sales, Revenue and Market Share by Country
      • 5.1.1 North America Retinal Pharmaceuticals Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Retinal Pharmaceuticals Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 5.3 Canada Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)

    6 Europe Retinal Pharmaceuticals by Country

    • 6.1 Europe Retinal Pharmaceuticals Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Retinal Pharmaceuticals Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Retinal Pharmaceuticals Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 6.3 UK Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 6.4 France Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 6.5 Russia Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 6.6 Italy Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Retinal Pharmaceuticals by Country

    • 7.1 Asia-Pacific Retinal Pharmaceuticals Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Retinal Pharmaceuticals Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Retinal Pharmaceuticals Revenue and Market Share by Country (2014-2019)
    • 7.2 China Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 7.3 Japan Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 7.4 Korea Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 7.5 India Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)

    8 South America Retinal Pharmaceuticals by Country

    • 8.1 South America Retinal Pharmaceuticals Sales, Revenue and Market Share by Country
      • 8.1.1 South America Retinal Pharmaceuticals Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Retinal Pharmaceuticals Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Retinal Pharmaceuticals by Countries

    • 9.1 Middle East and Africa Retinal Pharmaceuticals Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Retinal Pharmaceuticals Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Retinal Pharmaceuticals Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Retinal Pharmaceuticals Sales and Growth Rate (2014-2019)

    10 Global Retinal Pharmaceuticals Market Segment by Type

    • 10.1 Global Retinal Pharmaceuticals Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Retinal Pharmaceuticals Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Retinal Pharmaceuticals Revenue and Market Share by Type (2014-2019)
    • 10.2 Macular Degeneration Sales Growth and Price
      • 10.2.1 Global Macular Degeneration Sales Growth (2014-2019)
      • 10.2.2 Global Macular Degeneration Price (2014-2019)
    • 10.3 Diabetic Eye Disease Sales Growth and Price
      • 10.3.1 Global Diabetic Eye Disease Sales Growth (2014-2019)
      • 10.3.2 Global Diabetic Eye Disease Price (2014-2019)
    • 10.4 Retinal Detachment Sales Growth and Price
      • 10.4.1 Global Retinal Detachment Sales Growth (2014-2019)
      • 10.4.2 Global Retinal Detachment Price (2014-2019)
    • 10.5 Retinoblastoma Sales Growth and Price
      • 10.5.1 Global Retinoblastoma Sales Growth (2014-2019)
      • 10.5.2 Global Retinoblastoma Price (2014-2019)
    • 10.6 Macular Pucker Sales Growth and Price
      • 10.6.1 Global Macular Pucker Sales Growth (2014-2019)
      • 10.6.2 Global Macular Pucker Price (2014-2019)
    • 10.7 Macular Hole Sales Growth and Price
      • 10.7.1 Global Macular Hole Sales Growth (2014-2019)
      • 10.7.2 Global Macular Hole Price (2014-2019)
    • 10.8 Others Sales Growth and Price
      • 10.8.1 Global Others Sales Growth (2014-2019)
      • 10.8.2 Global Others Price (2014-2019)

    11 Global Retinal Pharmaceuticals Market Segment by Application

    • 11.1 Global Retinal Pharmaceuticals Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Pharmacies Sales Growth (2014-2019)
    • 11.3 Online Pharmacies Sales Growth (2014-2019)
    • 11.4 Independent Pharmacies Sales Growth (2014-2019)

    12 Retinal Pharmaceuticals Market Forecast (2019-2024)

    • 12.1 Global Retinal Pharmaceuticals Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Retinal Pharmaceuticals Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Retinal Pharmaceuticals Market Forecast (2019-2024)
      • 12.2.2 Europe Retinal Pharmaceuticals Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Retinal Pharmaceuticals Market Forecast (2019-2024)
      • 12.2.4 South America Retinal Pharmaceuticals Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Retinal Pharmaceuticals Market Forecast (2019-2024)
    • 12.3 Retinal Pharmaceuticals Market Forecast by Type (2019-2024)
      • 12.3.1 Global Retinal Pharmaceuticals Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Retinal Pharmaceuticals Market Share Forecast by Type (2019-2024)
    • 12.4 Retinal Pharmaceuticals Market Forecast by Application (2019-2024)
      • 12.4.1 Global Retinal Pharmaceuticals Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Retinal Pharmaceuticals Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Retinal Pharmaceuticals is primarily used to treat retinal-related diseases.
      Retina is a layer of nerve tissue lining the back of the eye. Retina receives light and convert it into neural signals, and send these signals to the brain for visual recognition. The central part of the retina is known as macula, which is responsible for central vision. The remaining tissue outside the macula is responsible for peripheral vision. There are many types of retinal diseases.

      Scope of the Report:
      The worldwide market for Retinal Pharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Retinal Pharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Santen Pharmaceutical Co.,Ltd.
      Regeneron Pharmaceuticals,Inc.
      Shire Plc
      Bayer AG
      Novartis International AG
      Valeant Pharmaceuticals International,Inc
      Merck&Co.

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Macular Degeneration
      Diabetic Eye Disease
      Retinal Detachment
      Retinoblastoma
      Macular Pucker
      Macular Hole
      Others

      Market Segment by Applications, can be divided into
      Hospital Pharmacies
      Online Pharmacies
      Independent Pharmacies

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Retinal Pharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Retinal Pharmaceuticals, with price, sales, revenue and global market share of Retinal Pharmaceuticals in 2017 and 2018.
      Chapter 3, the Retinal Pharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Retinal Pharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Retinal Pharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Retinal Pharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now